Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment. [electronic resource]
- Journal for immunotherapy of cancer 11 2019
- 309 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
2051-1426
10.1186/s40425-019-0769-8 doi
Antigens, Neoplasm--genetics Colorectal Neoplasms--genetics Female Histocompatibility Antigens Class I--genetics Humans Interferon-gamma--pharmacology MAP Kinase Kinase Kinases--antagonists & inhibitors Male Middle Aged Organoids--immunology Peptides--immunology Protein Kinase Inhibitors--pharmacology Proteomics